News | November 15, 2013

Hospital in Spain First to Treat Skin Cancer Patients With Esteya Electronic Brachytherapy System

Hospital La Fe's study demonstrates patient-friendliness, short procedure time with Esteya

radiation therapy brachytherapy nucletron elekta esteya hospital la fe
November 15, 2013 — Hospital La Fe, a clinical collaborator of Nucletron, an Elekta company, is nearing the conclusion of the enrollment phase of a clinical study with the Esteya electronic brachytherapy system for treating skin cancer. First clinical data on efficacy are expected in about two months, but physicians in the center's radiotherapy department are already reporting that patients have tolerated the treatments well and that the system is user-friendly.
 
The enrollment of the first group of 20 patients ever to receive treatment with Esteya, was completed in October. The center is using a standard treatment protocol of 36.6 Gy over six fractions, 6.1 Gy per fraction delivered twice weekly.
 
"The patients have accepted the treatment very well and side effects reported for the first treated patients have been very mild — typically just little skin reddening or itching," said José Perez-Calatayud, head of medical physics, Hospital La Fe. "The treatment delivery times have averaged less than three minutes per lesion, for a total treatment session of seven to eight minutes. This short therapy delivery is important, certainly, for patients with multiple lesions. One of the patients we treated had nine lesions."
 
"With five surface applicators ranging in size from 1 cm to 3 cm, we have a great opportunity to adapt to the lesion's size, thus helping us avoid exposing normal tissue," said Perez-Calatayud. "And the leakage dose — the dose outside the volume to be treated — is extremely low due to the combination of low energy and tungsten shielding of the applicators."
 
Planning and delivery of electronic brachytherapy at Hospital La Fe has been exceptionally straightforward.
 
"The graphical user interface is uncomplicated and patient setup is quite simple, contributing to a smooth, efficient workflow," said Perez-Calatayud.
 
For more information: www.esteya.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation